142 related articles for article (PubMed ID: 10749239)
1. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.
Berger KL; Nicholson SA; Dehdashti F; Siegel BA
AJR Am J Roentgenol; 2000 Apr; 174(4):1005-8. PubMed ID: 10749239
[TBL] [Abstract][Full Text] [Related]
2. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
3. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
De Potter T; Flamen P; Van Cutsem E; Penninckx F; Filez L; Bormans G; Maes A; Mortelmans L
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):525-9. PubMed ID: 11914891
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography with 2-deoxy-2-[(18)F] fluoro- d-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion.
Yoshioka M; Sato T; Furuya T; Shibata S; Andoh H; Asanuma Y; Hatazawa J; Koyama K
J Gastroenterol; 2003; 38(12):1189-93. PubMed ID: 14714260
[TBL] [Abstract][Full Text] [Related]
5. ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
Murakami S; Saito H; Karino F; Kondo T; Oshita F; Ito H; Nakayama H; Yokose T; Yamada K
Eur J Radiol; 2013 Nov; 82(11):e721-5. PubMed ID: 23988690
[TBL] [Abstract][Full Text] [Related]
6. PET/MRI Characterization of Mucinous Versus Nonmucinous Components of Rectal Adenocarcinoma: A Comparison of Tumor Metabolism and Cellularity.
Queiroz MA; Naves A; Dreyer PR; Cerri GG; Buchpiguel CA
AJR Am J Roentgenol; 2021 Feb; 216(2):376-383. PubMed ID: 33295813
[No Abstract] [Full Text] [Related]
7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of pancreatic carcinoma: role of FDG PET.
Keogan MT; Tyler D; Clark L; Branch MS; McDermott VG; DeLong DM; Coleman RE
AJR Am J Roentgenol; 1998 Dec; 171(6):1565-70. PubMed ID: 9843289
[TBL] [Abstract][Full Text] [Related]
9. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
Mansour JC; Schwartz L; Pandit-Taskar N; D'Angelica M; Fong Y; Larson SM; Brennan MF; Allen PJ
J Gastrointest Surg; 2006 Dec; 10(10):1354-60. PubMed ID: 17175454
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
[TBL] [Abstract][Full Text] [Related]
11. (18)F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes.
Dos Anjos DA; Habr-Gama A; Vailati BB; Rossi CB; Coturel AE; Perez RO; São Julião GP; de Sousa JB; Buchpiguel CA
Ann Nucl Med; 2016 Oct; 30(8):513-7. PubMed ID: 27251677
[TBL] [Abstract][Full Text] [Related]
12. A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT.
Li X; Liu S; Yao S; Wang M
Clin Nucl Med; 2015 Mar; 40(3):282-5. PubMed ID: 25608160
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Avril N; Menzel M; Dose J; Schelling M; Weber W; Jänicke F; Nathrath W; Schwaiger M
J Nucl Med; 2001 Jan; 42(1):9-16. PubMed ID: 11197987
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
16. Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings.
Sawada E; Nambu A; Motosugi U; Araki T; Kato S; Sato Y; Saito A; Ishihara H; Okuwaki H; Ozawa K; Nishikawa K; Miyazawa M; Miyata K
Jpn J Radiol; 2010 May; 28(4):251-8. PubMed ID: 20512541
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
Graeber GM; Gupta NC; Murray GF
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):719-27. PubMed ID: 10096967
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.
Wu HB; Wang L; Wang QS; Han YJ; Li HS; Zhou WL; Tian Y
Biomed Res Int; 2015; 2015():243681. PubMed ID: 25879020
[TBL] [Abstract][Full Text] [Related]
19. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
[TBL] [Abstract][Full Text] [Related]
20. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
